Overcoming MDR remains a major obstacle in cancer treatment, especially when resistance is driven by ABC transporters such as ABCG2 (Zhu et al., 2024; Koirala and DiPaola, 2024; Li et al., 2024a; To et al., 2024). The gene discussed is ABCG2; the disease is cancer.